Schedule 13G ownership disclosure

N/A

Common Stock · CUSIP: 73730P108

Event date: 2025-01-08

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Malin Life Sciences Holdings Limited

    Shares: 0.00 · Class: 0%

  • Malin Corporation plc

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-003781
Form type
SCHEDULE 13G/A
Filer
Malin Life Sciences Holdings Ltd
CIK
CIK 1685138
Filed
Jan 15, 2025
Reporting period
Jan 08, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub